Literature DB >> 31632662

CON: This Patient Should Have a Noninvasive Assessment of Liver Staging.

Rohit Nathan1, Deepanshu Jain1, Simona Rossi1.   

Abstract

Entities:  

Year:  2019        PMID： 31632662      PMCID： PMC6784798          DOI： 10.1002/cld.822

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


× No keyword cloud information.
  17 in total

1.  Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009.

Authors:  Zobair M Younossi; Munkhzul Otgonsuren; Linda Henry; Chapy Venkatesan; Alita Mishra; Madeline Erario; Sharon Hunt
Journal:  Hepatology       Date:  2015-10-24       Impact factor: 17.425

Review 2.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.

Authors:  Siddharth Singh; Alina M Allen; Zhen Wang; Larry J Prokop; Mohammad H Murad; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2014-04-24       Impact factor: 11.382

Review 3.  The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases.

Authors:  Naga Chalasani; Zobair Younossi; Joel E Lavine; Michael Charlton; Kenneth Cusi; Mary Rinella; Stephen A Harrison; Elizabeth M Brunt; Arun J Sanyal
Journal:  Hepatology       Date:  2017-09-29       Impact factor: 17.425

Review 4.  Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD.

Authors:  Elliot B Tapper; Rohit Loomba
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-02-21       Impact factor: 46.802

5.  Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis.

Authors:  Zobair M Younossi; Rohit Loomba; Quentin M Anstee; Mary E Rinella; Elisabetta Bugianesi; Giulio Marchesini; Brent A Neuschwander-Tetri; Lawrence Serfaty; Francesco Negro; Stephen H Caldwell; Vlad Ratziu; Kathleen E Corey; Scott L Friedman; Manal F Abdelmalek; Stephen A Harrison; Arun J Sanyal; Joel E Lavine; Philippe Mathurin; Michael R Charlton; Zachary D Goodman; Naga P Chalasani; Kris V Kowdley; Jacob George; Keith Lindor
Journal:  Hepatology       Date:  2018-07       Impact factor: 17.425

6.  Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients.

Authors:  Robert P Myers; Gilles Pomier-Layrargues; Richard Kirsch; Aaron Pollett; Andres Duarte-Rojo; David Wong; Melanie Beaton; Mark Levstik; Pam Crotty; Magdy Elkashab
Journal:  Hepatology       Date:  2011-11-18       Impact factor: 17.425

7.  Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy.

Authors:  Christophe Cassinotto; Jérome Boursier; Victor de Lédinghen; Jérome Lebigot; Bruno Lapuyade; Paul Cales; Jean-Baptiste Hiriart; Sophie Michalak; Brigitte Le Bail; Victoire Cartier; Amaury Mouries; Frédéric Oberti; Isabelle Fouchard-Hubert; Julien Vergniol; Christophe Aubé
Journal:  Hepatology       Date:  2016-01-22       Impact factor: 17.425

8.  Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness.

Authors:  Jeremy Chak-Lun Chow; Grace Lai-Hung Wong; Anthony Wing-Hung Chan; Sally She-Ting Shu; Carmen Ka-Man Chan; Julie Ka-Yu Leung; Paul Cheung-Lung Choi; Angel Mei-Ling Chim; Henry Lik-Yuen Chan; Vincent Wai-Sun Wong
Journal:  J Gastroenterol Hepatol       Date:  2018-06-27       Impact factor: 4.029

9.  Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

Authors:  Raj Vuppalanchi; Aynur Unalp; Mark L Van Natta; Oscar W Cummings; Kumar E Sandrasegaran; Tariq Hameed; James Tonascia; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2008-12-25       Impact factor: 11.382

10.  Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study.

Authors:  Rohit Loomba; Tanya Wolfson; Brandon Ang; Jonathan Hooker; Cynthia Behling; Michael Peterson; Mark Valasek; Grace Lin; David Brenner; Anthony Gamst; Richard Ehman; Claude Sirlin
Journal:  Hepatology       Date:  2014-10-29       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.